
The mining sector is booming right now and one ASX technology stock stands to benefit greatly.
That stock is Chrysos Corporation Ltd (ASX: C79), which provides novel assay services to the global mining industry through its proprietary PhotonAssay technology.
PhotonAssay can be used to detect a wide range of elements, but the technology has been particularly effective for assaying gold and is currently being rolledâout across the gold mining industry.
Bell Potter is a big fan of the company and is recommending the stock to clients following its half-year results release this month.
What is the broker saying?
The broker notes that the ASX mining technology stock delivered a half-year result that was ahead of expectations thanks to higher PhotonAssay fleet utilisation. It said:
Total revenue was $43.3m (BPe $41.7m), up 49% YoY, with MMAP of $31.5m (BPe $32.6m), up 22% YoY, and AAC of $11.7m (BPe $9.1m), up 261% YoY. MMAP growth was driven by an expansion in the installed base. The significant uptick in AAC was due to higher PhotonAssay fleet utilisation as rising global exploration activity drove greater samples processed. Four additional units were deployed during the half, taking total units installed and operational to 43. GM was 76.3% (BPe 78.0%), up from 72.9% in the PcP.
EBITDA of $14.4m (BPe $13.2m) was up 152%, with margins improving to 33.1% (BPe 31.6%), up from 19.5% in the PcP, reflecting operating leverage and greater AAC. Underlying NPAT was $0.7m (BPe $1.8m), up from a $2.6m loss in the PcP.
Guidance upgrade
Bell Potter was also pleased to see that management has upgraded its guidance for the full year. It adds:
A soft upgrade was delivered: Revenue is now tracking towards the top-end of the $80-90m range (BPe $90.8m old); and EBITDA is now tracking towards the top-end of the $20-27m range (BPe $29.6m old). We see guidance as conservative due to: 1) an acceleration in deployment cadence in 2H FY26 given the significant expansion in the backlog following the 14 new lease agreements secured in FY26TD; and 2) strong ongoing momentum in exploration activity enhancing the outlook for AAC generation.
Strong potential returns
According to the note, the broker has retained its buy rating and $9.40 price target on the ASX mining technology stock.
Based on its current share price of $7.93, this implies potential upside of 19% for investors over the next 12 months.
Commenting on its buy recommendation, the broker concludes:
We are encouraged by the 14 lease agreements signed in FY26TD, expanding on existing relationships and securing contracts with new prospective clients. Together, with the landmark Newmont MSA, the increased contract award momentum signals an acceleration in PhotonAssay adoption, which is a key tenet to our Buy thesis.
The post Here’s an exciting ASX mining technology stock to buy appeared first on The Motley Fool Australia.
Should you invest $1,000 in Chrysos right now?
Before you buy Chrysos shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Chrysos wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- PLS Group posts H1 FY26 profit and 241% EBITDA surge
- HUB24 delivers 1HFY26 earnings and raises FY27 growth target
- Transurban posts higher 1H26 profit and revenue as key projects open
- Invested in the VanEck MSCI International Value ETF (VLUE)? Here are the stocks you own
- Telstra lifts earnings and dividend, expands buy-back for 1H26
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Chrysos. The Motley Fool Australia has positions in and has recommended Chrysos. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.